BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15566648)

  • 1. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
    Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
    Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
    Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
    Pinto AE; André S; Pereira T; Silva G; Soares J
    Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
    Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
    Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative study of P53 gene protein expression in the benign disease and cancer of breast].
    Qi FY; Zuo LF; Zhen YJ
    Zhonghua Bing Li Xue Za Zhi; 1994 Dec; 23(6):330-3. PubMed ID: 7720109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the relationship between CD44v6, p53 gene mutation and ovarian carcinoma metastasis].
    Sun Y; Shen Z; Ji X
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):225-8. PubMed ID: 11776166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
    Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
    Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
    Liu YJ; Yan PS; Li J; Jia JF
    World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer.
    Railo M; Lundin J; Haglund C; von Smitten K; Nordling S
    Tumour Biol; 2007; 28(1):45-51. PubMed ID: 17143016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CD44s, CD44v3 and CD44v6 in breast cancer.
    Wu XJ; Li XD; Zhang H; Zhang X; Ning ZH; Yin YM; Tian Y
    J Int Med Res; 2015 Apr; 43(2):173-9. PubMed ID: 25571897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship of expression of CD44v6 with metastasis and prognosis in breast cancer].
    Deng Y; Ma W; Fang X; Zheng S
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):451-2. PubMed ID: 11832082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytometry-pathology combined study of breast cancer].
    Yu ZY; Yu JM; Wu TH; Zhuo PY; Wang SF; Li M; Zhang X; Lü BY; Liu YB
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):420-2. PubMed ID: 16188128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of chemotactic factor receptor 5 gene with breast cancer.
    Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
    Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA content analysis of breast cancer cells recognized by monoclonal antibody].
    Zhu LW
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):347-50. PubMed ID: 8174478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.